Agoracom Blog Home

Archive for the ‘North Bud Farms Inc’ Category

#Marijuana shortages abound in Canada in just second week of legalization $BOG.ca NBUD.ca $MCOA $ACG.ca $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 10:54 AM on Monday, October 29th, 2018

  • The Canadian cannabis industry is still reeling from sky-high demand in the second week of legalization, with growers expressing frustration at the length of time it’s taking to get licensed as shelves sit empty.
  • “We’re biting our nails and I think our shareholders are biting their nails too,” said Anthony Durkacz, director at FSD Pharma Inc., an Ontario-based producer that received its cultivation licence a year ago and is still waiting for its sales licence. “We want to be supplying.”

People check out the sample counter at a cannabis store in Winnipeg, Man., on Oct. 17.Canadian Press/John Woods

Kristine Owram

The Canadian cannabis industry is still reeling from sky-high demand in the second week of legalization, with growers expressing frustration at the length of time it’s taking to get licensed as shelves sit empty.

“We’re biting our nails and I think our shareholders are biting their nails too,” said Anthony Durkacz, director at FSD Pharma Inc., an Ontario-based producer that received its cultivation licence a year ago and is still waiting for its sales licence. “We want to be supplying.”

Every province, not just Manitoba, is receiving less cannabis than originally requested

The process of getting a sales licence from Health Canada is onerous, according to Durkacz. After receiving a cultivation license, a grower must produce two full crops, send them off for testing, get its sales software audited, and then submit a completed application for the sales licence, which can take up to 341 days to process, he said.

“So even after you’ve done everything and done everything right you could be waiting up to a year to get the licence,” he said.

Customers lineup at a government cannabis store Oct. 19, in Montreal on the third day of the legal cannabis sales in Canada. Canadian Press/Ryan RemiorzCanada became the first major economy to legalize recreational cannabis on Oct. 17, taking the lead in a global market that’s expected to reach US$32 billion in consumer spending by 2022, according to Arcview Market Research and BDS Analytics. The euphoria that sent pot stocks soaring in the lead-up to legalization has faded, with the BI Canada Cannabis Competitive Peers index losing 26 per cent over seven sessions before rebounding on Thursday.

While some growers wait for their licences, others are struggling to keep up with demand. The government-run Ontario Cannabis Store received 100,000 orders in its first 24 hours. In Quebec, online and in-store orders totalled nearly 140,000 in the first week of legalization, and the provincial-owned retailer indicated Wednesday it may have to close some locations as producers couldn’t meet demand. Producers will have a “colossal” amount of work to do to ensure supply, the Societe Quebecoise du Cannabis said in a statement.

A man holds a bag of marijuana he bought in a cannabis store in Quebec City, on Oct. 17. Alice Chiche/AFP/Getty ImagesThe problem is that no one knew what the demand curve would look like after a century of prohibition, said Bruce Linton, chief executive officer of Canopy Growth Corp., which has secured more than a third of total Canadian supply committed to date.

Canopy shipped approximately 1 million orders of medical cannabis in its first four years of operations. It expects to ship more than 1 million units of recreational pot in the first four weeks after legalization, Linton said.

‘Just Outstanding’

“The response has been pretty unbelievable,” Linton said. “I don’t think everything will run out but you might not be able to get the identical stuff you got last time.”

He added that Canopy is sending out orders as fast as it can pack and ship them, but there have been delays in getting new product up on the provincial websites. It will start shipping out new products, including Tweed-brand gel caps and pre-rolled joints, over the next week and a half.

Bruce Linton (left), Canopy Growth CEO, in St. Johns, Newfoundland sells the first gram of legal pot at the Tweed store at the stroke of midnight Oct. 17. Julie Oliver/PostmediaInitial demand at Alberta Gaming, Liquor and Cannabis was “just outstanding,” said Chara Goodings, a spokeswoman for the government regulator that’s overseeing sales in the western province. “But it has created some struggles with our supply level.” Very few producers have been able to deliver what was agreed upon, she said.

Dried Bud

The situation is similar in Manitoba, where Winnipeg-based Delta 9 Cannabis Inc. only has dried bud on its store shelves as it has been unable to get any shipments of cannabis oils or gel caps, said spokesman Gary Symons. In the first seven days, Delta 9 saw close to 9,600 transactions totalling $736,124 in revenues. The company is now selling about $50,000 worth of product a day.

“Every province, not just Manitoba, is receiving less cannabis than originally requested,” Susan Harrison, spokeswoman for Manitoba Liquor & Lotteries, said in an email.

Aphria Inc. CEO Vic Neufeld predicted the supply shortages on the company’s earnings call five days before legalization. Citing supply-chain issues, labor shortages and delays in getting licences and excise stamps from the government, Neufeld said Aphria would be unable to meet demand in the first two to three months after legalization. The company was forced to destroy almost 14,000 plants worth $979,000 in the last quarter due to a lack of qualified greenhouse workers.

Extra Staff

There are currently 132 licensed producers in Canada and “many more are in the queue,” said Canadian Health Minister Ginette Petitpas Taylor. Health Canada has hired 300 additional staff to evaluate applications, she said. But the process, which includes background checks, is time-consuming and it’s important to not cut corners, she said.

“There’s not a mass shortage of cannabis around the country right now,” only certain strains that have sold out, Petitpas Taylor said. “We really have all hands on deck, we want to do what we can, but in no way am I going to compromise this new regime.”

The challenge for the government is balancing public safety with a desire to eradicate the illicit market, said Deepak Anand, vice president of business development and government relations at Cannabis Compliance Inc., a consulting firm for pot companies which is currently working on “hundreds” of licensing applications.

“Health Canada’s trying to balance quality and public safety with the need for getting more product on so that they can eliminate the black market,” Anand said. “Sometimes these goals conflict and compete with each other.”

The only near-term solution to the supply shortage, according to Durkacz at FSD Pharma, is to allow retailers to sell product sourced from the black market.

“You would instantaneously have a supply-demand balance and then you could try to convert people from the black market to the legalized market,” he said. “That’s probably the only way to solve this in the short term.”

Source: https://business.financialpost.com/cannabis/cannabis-business/marijuana-shortages-abound-in-canada-amid-licensing-rigmarole

#Marijuana Stocks: Three Key Catalysts for Further Growth $BOG.ca $NBUD.ca $MCOA $AERO $CBDS $CGRW $APH.ca $GBLX $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 1:59 PM on Friday, October 26th, 2018

For most of 2018, marijuana stocks were the hottest opportunities around.

• Canopy Growth (CGC) ran from $20 to $57

• Tilray Inc. (TLRY) ran from $20 to $300

• OrganiGram Holdings (OGRMF) ran from $3 to $6.75

• Marijuana ETF, MJ ran from $26 to more than $44

All on anticipatory momentum as we neared Canadian approval this month. However, once the news was out, related stocks began to pull back on a “sell the news” reaction.

Once an expected catalyst is out, these are to be expected.

However, don’t count out marijuana stocks so fast, though. The catalysts ahead are monumental.

One – Americans Greatly Support its Legalization

A growing majority of Americans fully support its legalization, which has led to its decriminalization and the potential for significant cash inflows. In fact, 66% of Americans now support legalizing marijuana, another new high in Gallup’s trend. The latest figure marks the third consecutive year that support has increased.

Already, nine states and D.C. have legalized marijuana for recreational use.

As more states move to legalize its use, sales will skyrocket, in our opinion.

Two – Canada is Only the Start of the Boom

On October 17, 2018, marijuana became legal in Canada. But no one expected the demand to be as strong as it’s been. In fact, according to Fortune, the country can’t keep up with the pace of demand. Retail shops are nearly sold out.

It’s gotten so bad that stores have closed until the supply problem is fixed.

By 2021 analysts say Canada could have nearly four million recreational marijuana users, creating a monstrous $4.5 billion industry. The industry could balloon to $8.7 billion shortly thereafter, as marijuana retail sales just in Canada are likely to surpass beer, wine and spirit sales combined. That’s big money.

Three – Corporate America is on Board with Marijuana

As sales of beer fall in the United States, brewers have begun to bet that legalization of marijuana around the globe, especially the United States, will continue to build momentum and sales of cannabis products will take off.

Molson Coors for example listed legal cannabis among the biggest possible risks to its business in its annual shareholder report.

Even Bill Gates’ Microsoft jumped into the cannabis business on the software side, partnering with Kind Financial. The software will give governments and business owners a way to monitor the distribution of cannabis “from seed to sale” and ensure compliance.

Hewlett-Packard powers the Flowhub cannabis compliance solutions, too. Flowhub’s product not only provides business management and transactional processing tools for retail stores but also workflow focused on compliance, regulatory and reporting rules of marijuana dispensaries.

However, this is – we believe – is only the start. Pay close attention to this space.

Source: https://www.chasingmarkets.com/news/15bd33a6521b01/Marijuana_Stocks%3A_Three_Key_Catalysts_for_Further_Growth

Demand for #marijuana real estate ‘astronomical’ as Canada legalizes $BOG.ca $NBUD.ca $MCOA $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 10:32 AM on Wednesday, October 24th, 2018
  • Demand for marijuana facilities, including greenhouses, indoor grow-ops and warehouses will put more demand on the country’s already tight supply of industrial real estate.
  • British Columbia and Ontario combined took up more than half of the existing grow-op space, Altus said.

The rush for cannabis is on in Canada and so is finding the real estate to grow it.

The legalization of recreational weed on Wednesday has already fuelled a sixfold surge in pot-growing facilities to 8.7 million square feet (808,256 square meters) in the year through September, according to data from Altus Group Ltd. — space about the size of Amazon.com Inc.’s Seattle headquarters. Publicly listed companies have another 6.4 million square feet on the drawing board, not including retail.

“It’s grown astronomically,” Raymond Wong, vice president of data operations at Toronto-based Altus, said by phone. “With the publicly traded companies, there’s a lot more investment in these areas with anticipated growth and available capital, and they’re acquiring and expanding their existing facilities.”

The demand for marijuana facilities, including greenhouses, indoor grow-ops and warehouses will put more demand on the country’s already tight supply of industrial real estate. British Columbia and Ontario combined took up more than half of the existing grow-op space, Altus said.

Wong said expansion plans are likely conservative as it excludes private companies’ anticipated growth. “There’s a whole other market out there that anticipates further growth in this area,” he said. “We don’t see this slowing down.”

Source: https://business.financialpost.com/real-estate/property-post/demand-for-pot-grow-ops-is-astronomical-as-canada-legalizes

Canada Running Short Of #Marijuana After Legalization $BOG.ca $NBUD.a $MCOA $TBP.ca $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 9:54 AM on Monday, October 22nd, 2018

  • Just two days after it legalized the sale and personal use of recreational marijuana on Oct. 17, Canada has found itself suffering from a shortage of the commodity
  • Canadian cannabis producers and stores apparently underestimated the huge surge in demand for cannabis following its legalization.

Oct 22, 2018 06:47 PM

The United States might be in for the same surprise when it legalizes the use of recreational marijuana or cannabis in the future.

Just two days after it legalized the sale and personal use of recreational marijuana on Oct. 17, Canada has found itself suffering from a shortage of the commodity. Canadian cannabis producers and stores apparently underestimated the huge surge in demand for cannabis following its legalization.

Under the new law, Canadian citizens will be allowed to carry up to 30 grams of cannabis in public and each household will be able to grow up to four marijuana plants.

Statistics Canada, the country’s national statistics agency, estimated that 5.4 million Canadians will buy cannabis from legal dispensaries in 2018. That’s about 15 percent of the population. In addition, some 4.9 million Canadians already smoke weed. These projections included a boost from legalization but were still off the mark due to the high demand for cannabis.

Bill Blair, who led the government’s cannabis legalization program, said the country is unable to supply enough to meet demand. He said the government expected “certain strains might run out and there would be a bit of a run on supply.”

Cannabis supply began running low on Oct. 19. The supply dearth saw retailers are turning people away because they’d run out of stock.

The Ontario Cannabis Retail Corporation, the sole legal retailer of recreational cannabis in the province of Ontario, said some cannabis items are unavailable on its website. It said given the scarcity of cannabis products across Canada, it expects “significant” short-term supply problems.

Cannabis retailers in Alberta and Prince Edward Island said certain cannabis products quickly sold out online after vigorous business on their cannabis sales websites on the first day of legalization. Experts said the supply shortage situation is the same across Canada.

Experts said the shortage of cannabis brings with it the risk Canada might soon run out of practically its entire inventory of cannabis products. The situation is due to supply and demand with many users stocking-up due to worries there might not be enough stock in the stores over the next few weeks.

Cannabis demand is under threat because supply didn’t ramp up to meet demand, said marijuana advocate Steven Stairs. He expects the government to step in and try to ensure supply by mitigating regulation and taxation.

The Cannabis Commerce Association of Canada said most of the cannabis produced in Canada right now doesn’t come from the black market but rather from medically licensed growers, or the grey market. These licensed growers weren’t able to ramp-up production in time to meet demand because weed wasn’t legal at the time so there was no sense in boosting production.

Growers also held off on planting more weed because licenses allowing them to do so weren’t available before Oct. 17. Those who applied on Oct. 17 are still waiting for their applications to be processed.

Source: http://en.businesstimes.cn/articles/104225/20181022/canada-running-short-marijuana-legalization.htm

No. 1 Wall Street #pot analyst says the #marijuana market will be much bigger than she first thought $BOG.ca $NBUD.ca $MCOA $APPB

Posted by AGORACOM-JC at 10:53 AM on Friday, October 12th, 2018
  • The cannabis industry’s rapid evolution and new strategic partnerships with mainstream brands reveal a far larger possible market for legal marijuana than investors and analysts first anticipated, according to Cowen.
  • Cowen’s Vivien Azer nearly triples her 12-month price forecast on Canadian marijuana producer Tilray this week to $172 from $62.
  • Recreational use of cannabis in Canada becomes legal Oct. 17, though each of the country’s 10 provinces will be able to regulate the market within their jurisdiction.

Wall Street’s top pot analyst says marijuana market will be much bigger than she first thought   23 Hours Ago | 00:58

With Canada about to legalize recreational use of marijuana, the industry’s rapid evolution and new strategic partnerships with mainstream brands reveal a far larger possible market for pot than investors and analysts first anticipated, according to Cowen.

“With cannabis, you’re talking about this massive step change in terms of the addressable market,” Vivien Azer said on CNBC’s “Squawk Box” on Wednesday. “You’re bringing a $7 billion illicit market into the legal market and so it does require a different valuation framework.”

Azer, the only pot analyst from a major Wall Street research house, nearly tripled her 12-month price forecast on Canadian marijuana producer Tilray this week to $172 from $62. The new target for the stock, which trades in the U.S. on the Nasdaq, implies more than 30 percent upside from current levels. She also upped her forecast on Canadian pot company Canopy Growth.

Supply remains critical issues for cannabis companies, says analyst   8:17 AM ET Wed, 10 Oct 2018 | 01:51

Just how big the market will get is tough to put a number on right now, but Azer cites a cannabis executive who estimated the market could be one day worth $500 billion.

“Our broader, big picture view of cannabis goes beyond the adult use launch in Canada,” she wrote in a report this week. “Rather, we believe this is the first step toward the establishment of cannabis as a key functional ingredient touching multiple consumer categories with four key verticals: adult use, beauty and nutraceuticals, OTC pain and sleep, and pharmaceuticals.”

Recreational use of cannabis in Canada becomes legal Oct. 17, though each of the country’s 10 provinces will be able to regulate the market within their jurisdiction independent of Ottawa.

While it’s still early days for the marijuana business, the first signs of its broader applications are easily recognized.

Tilray shares, which are up more than 650 percent since their July IPO, posted one of their best days ever mid-September after the company announced approval from the Drug Enforcement Administration to import weed to the U.S. for medical research.

In a move likely foreshadowing broader pharmaceutical application, the company will work with the University of California San Diego Center for Medicinal Cannabis Research to study the safety, tolerability and efficacy of marijuana for a neurological disorder.

“If this study can identify cannabinoids as a potential treatment for patients suffering from essential tremor, we can conduct further research and potentially provide alternative effective methods of relief for the high numbers of patients with Essential Tremor,” said Catherine Jacobson, director of clinical research at Tilray.

The globe’s major alcohol companies have also wasted no time exploring joint ventures with a handful of lucky cannabis producers.

Alcohol vs. Cannabis use in the U.S.

Constellation Brands recently increased its investment in Canopy Growth with a 9.9 percent stake in the company, granting the Corona beer brewer a foothold in an industry it expects to soon be legal in the United States.

“We think that we’re by far the best company in the world — or in the best position in the world of any company — to capitalize on what is absolutely without a doubt going to be a huge market over the next 10 years, hundreds of billions of dollars,” Constellation CEO Robert Sands said in the company’s earnings call Thursday.

“We expect to reap the benefits of our cannabis investment, which we see as being incremental to our core beer, wine and spirits portfolio,” he added.

Richard Lautens | Toronto Star | Getty Images
Dried plants are processed and trimmed by hand. A a state-of-the-art fully automated medical marijuana production facility is in a nondescript building in Scarborough.

And while the upside for Constellation appears obvious, the benefit is two-fold. A check from one of the world’s largest brewers is a welcome influx of capital for a handful of companies whose success will likely be defined by their ability to raise capital and scale production.

“Given the nascent stage of global cannabis, we believe that revenue growth should serve as the primary valuation methodology,” Cowen’s Azer said in her note. Specifically, Azer said her primary measurement when drawing price estimates is enterprise value divided by sales, divided by revenue growth, akin to a traditional price/earnings growth ratio.

Some Wall Street firms cover the pot stocks, but none the size of Cowen. It’s still an emerging industry.

To be sure, the spike in certain pot stocks — combined with a limited count of floating shares for some companies — has left stocks like Tilray and Canopy with lofty valuations and rampant volatility.

Tilray has about 93 million shares outstanding, but the float — those shares actually available for trading — is just 21 million, according to FactSet.

Tilray’s 2020 P/E ratio, meanwhile, is currently 300; Canopy’s is 125. Tilray’s stock price has posted no less than 12 days of double-digit moves on percentage basis in the last month.

“There have been no shortage of recent catalysts to spur market and investor interest,” Azer said. “As such, volatility should be seen as a natural occurrence in the cannabis market, and not dissimilar to other nascent industries.”

https://www.cnbc.com/2018/10/10/top-pot-analyst-says-weed-market-bigger-than-first-thought.html

Canada to Open More Than 100 Pot Shops as It Becomes the Second Country to Legalize Marijuana $BOG.ca $NBUD.ca $MCOA $AERO $CBDS $CGRW $APH.ca $GBLX $ACG $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 2:26 PM on Thursday, October 11th, 2018

  • On Oct. 17, Canada becomes the second and largest country with a legal national marijuana marketplace. Uruguay launched legal sales last year, after several years of planning.
  • It’s a profound social shift promised by Canadian Prime Minister Justin Trudeau and fueled by a desire to bring the black market into a regulated, taxed system after nearly a century of prohibition.

(DELTA, British Columbia) — Mat Beren and his friends used to drive by the vast greenhouses of southern British Columbia and joke about how much weed they could grow there.

Years later, it’s no joke. The tomato and pepper plants that once filled some of those greenhouses have been replaced with a new cash crop: marijuana. Beren and other formerly illicit growers are helping cultivate it. The buyers no longer are unlawful dealers or dubious medical dispensaries; it’s the Canadian government.

On Oct. 17, Canada becomes the second and largest country with a legal national marijuana marketplace. Uruguay launched legal sales last year, after several years of planning.

It’s a profound social shift promised by Canadian Prime Minister Justin Trudeau and fueled by a desire to bring the black market into a regulated, taxed system after nearly a century of prohibition.

It also stands in contrast to the United States, where the federal government outlaws marijuana while most states allow medical or recreational use for people 21 and older. Canada’s national approach has allowed for unfettered industry banking, inter-province shipments of cannabis, online ordering, postal delivery and billions of dollars in investment; national prohibition in the U.S. has stifled greater industry expansion there.

Hannah Hetzer, who tracks international marijuana policy for the New York-based Drug Policy Alliance, called Canada’s move “extremely significant,” given that about 25 countries have already legalized the medical use of marijuana or decriminalized possession of small amounts of pot. A few, including Mexico, have expressed an interest in regulating recreational use.

“It’s going to change the global debate on drug policy,” she said. “There’s no other country immediately considering legalizing the nonmedical use of cannabis, but I think Canada will provide almost the permission for other countries to move forward.”

At least 109 legal pot shops are expected to open across the nation of 37 million people next Wednesday, with many more to come, according to an Associated Press survey of the provinces. For now, they’ll offer dried flower, capsules, tinctures and seeds, with sales of marijuana-infused foods and concentrates expected to begin next year.

The provinces are tasked with overseeing marijuana distribution. For some, including British Columbia and Alberta, that means buying cannabis from licensed producers, storing it in warehouses and then shipping it to retail shops and online customers. Others, like Newfoundland, are having growers ship directly to stores or through the mail.

Federal taxes will total $1 per gram or 10 percent, whichever is more. The feds will keep one-fourth of that and return the rest to the provinces, which can add their own markups. Consumers also will pay local sales taxes.

Some provinces have chosen to operate their own stores, like state-run liquor stores in the U.S., while others have OK’d private outlets. Most are letting residents grow up to four plants at home.

Canada’s most populous province, Ontario, won’t have any stores open until next April, after the new conservative government scrapped a plan for state-owned stores in favor of privately run shops. Until then, the only legal option for Ontario residents will be mail delivery — a prospect that didn’t sit well with longtime pot fan Ryan Bose, 48, a Lyft driver.

“Potheads are notoriously very impatient. When they want their weed, they want their weed,” he said after buying a half-ounce at an illicit medical marijuana dispensary in Toronto. “Waiting one or two three days for it by mail, I’m not sure how many will want to do that.”

British Columbia, home of the “B.C. Bud” long cherished by American pot connoisseurs, has had a prevalent marijuana culture since the 1970s, after U.S. draft-dodgers from the Vietnam War settled on Vancouver Island and in the province’s southeastern mountains. But a change in government last year slowed cannabis distribution plans there, too, and it will have just one store ready next Wednesday: a state-run shop in Kamloops, a few hours’ drive northeast of Vancouver. By contrast, Alberta expects to open 17 next week and 250 within a year.

No immediate crackdown is expected for the dozens of illicit-but-tolerated medical marijuana dispensaries operating in British Columbia, though officials eventually plan to close any without a license. Many are expected to apply for private retail licenses, and some have sued, saying they have a right to remain open.

British Columbia’s ministry of public safety is forming a team of 44 inspectors to root out unlawful operations, seize product and issue fines. They’ll have responsibility for a province of 4.7 million people and an area twice as large as California, where the black market still dwarfs the legal market that arrived in January.

Chris Clay, a longtime Canadian medical marijuana activist, runs Warmland Centre dispensary in an old shopping mall in Mill Bay, on Vancouver Island. He is closing the store Monday until he gets a license; he feared continuing to operate post-legalization would jeopardize his chances. Some of his eight staff members will likely have to file for unemployment benefits in the meantime.

“That will be frustrating, but overall I’m thrilled,” Clay said. “I’ve been waiting decades for this.”

The federal government has licensed 120 growers, some of them enormous. Canopy Growth, which recently received an investment of $4 billion from Constellation Brands, whose holdings include Corona beer, Robert Mondavi wines and Black Velvet whiskey, is approved for 5.6 million square feet (520,000 square meters) of production space across Canada. Its two biggest greenhouses are near the U.S. border in British Columbia.

Beren, a 23-year cannabis grower, is a Canopy consultant.

“We used to joke around all the time when we’d go to Vancouver and drive by the big greenhouses on the highway,” he said. “Like, ‘Oh man, someday. It’d be so awesome if we could grow cannabis in one of these greenhouses.’ We drive by now, and we’re like, ‘Oh, we’re here.’”

Next to Canopy’s greenhouse in Delta is another huge facility, Pure Sunfarms, a joint venture between a longtime tomato grower, Village Farms International, and a licensed medical marijuana producer, Emerald Health Therapeutics. Workers pulled out the remaining tomato plants last winter and got to work renovating the greenhouse as a marijuana farm, installing equipment that includes lights and accordion-shaped charcoal vents to control the plant’s odor. By 2020, the venture expects to move more than 165,000 pounds (75,000 kg) of bud per year.

Some longtime illegal growers who operate on a much smaller scale worry they won’t get licensed or will get steamrolled by much larger producers. Provinces can issue “micro-producer” licenses. But in British Columbia, where small-time pot growers helped sustain rural economies as the mining and forestry industries cratered, the application period hasn’t opened yet.

Sarah Campbell of the Craft Cannabis Association of BC said many small operators envision a day when they can host visitors who can tour their operations and sample the product, as wineries do.

Officials say they intend to accommodate craft growers but first need to ensure there is enough cannabis to meet demand when legalization arrives. Hiccups are inevitable, they say, and tweaks will be needed.

“Leaving it to each province to decide what’s best for their communities and their citizens is something that’s good,” said Gene Makowsky, the Saskatchewan minister who oversees the province’s Liquor and Gaming Authority. “We’ll be able to see if each law is successful or where we can do better in certain areas.”

British Columbia safety minister Mike Farnworth said he learned two primary lessons by visiting Oregon and Washington, U.S. states with recreational marijuana. One was not to look at the industry as an immediate cash cow, as it will take time to displace the black market. The other was to start with relatively strict regulations and then loosen them as needed, because it’s much harder to tighten them after the fact.

Legalization will be a process more than a date, Farnworth said.

“Oct. 17th is actually not going to look much different than it does today,” he said.

Source: http://time.com/5421443/canada-legal-marijuana-sales/

#Cannabis-laced drinks could be a US$600m market in US by 2022 $NBUD.ca $TAP $WEED.ca $KO

Posted by AGORACOM-JC at 10:18 AM on Friday, September 28th, 2018
  • Beverages with CBD (cannabidiol) or THC (tetrahydrocannabinol) ingredients could grow to capture about 20 per cent of the US market for edible pot products by 2022, up from 6 per cent of edibles sold now
  • Canaccord sees the demand for beverages featuring CBD, the non-psychoactive compound in marijuana, reaching US$260 million by 2022, up from the “negligible revenue” the limited number of drinks contributes now, while THC-based drinks could reach US$340 million, up from US$106 million expected this year

Sep 27, 2018 (Euclid Infotech Ltd via COMTEX) — Drinks infused with marijuana-derived compounds could swell to become a US$600 million market in the US within the next four years, outpacing the growth of other categories of retail cannabis products, according to analysts at Canaccord Genuity.

Beverages with CBD (cannabidiol) or THC (tetrahydrocannabinol) ingredients could grow to capture about 20 per cent of the US market for edible pot products by 2022, up from 6 per cent of edibles sold now, Canaccord’s Bobby Burleson wrote in a note. It’s an opportunity mainstream beer and soda makers are eager to take part in – Corona-parent Constellation Brands Inc became the largest stakeholder in Canadian pot cultivator Canopy Growth Corp earlier this year, while Molson Coors Canada formed a joint venture with Hexo Corp. Also, Coca-Cola Co said it’s exploring the idea.

“Interest has spiked from the beer industry on mounting evidence of a substitution relationship between cannabis and alcohol, while large soda companies increasingly view CBD as a natural fit within their strategically important wellness offerings,” Mr Burleson wrote.

Canaccord sees the demand for beverages featuring CBD, the non-psychoactive compound in marijuana, reaching US$260 million by 2022, up from the “negligible revenue” the limited number of drinks contributes now, while THC-based drinks could reach US$340 million, up from US$106 million expected this year.

Source: https://www.marketwatch.com/press-release/united-states-cannabis-laced-drinks-could-be-a-us600m-market-in-us-by-2022-2018-09-27

North Bud Farms $NBUD.ca Announces Licensing of #Cannabinoid Infusion Technology for Food and Beverage Platform $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 4:13 PM on Thursday, September 27th, 2018

Northbud large

  • Announced the licensing of infusion technology for its food and beverage platform with Made By Science Inc., a wholly owned subsidiary of Form Factory Inc.
  • Company signed a supply and licensing agreement with Made By Science Inc. , an Oregon, California multi state co-packaging and infused product manufacturer.
  • MBS owns a variety of IP protected infusion, encapsulation, taste masking and manufacturing processes

TORONTO, Sept. 27, 2018 – North Bud Farms Inc. (CSE: NBUD) (“NORTHBUD” or the “Company”) is pleased to announce the licensing of infusion technology for its food and beverage platform with Made By Science Inc., a wholly owned subsidiary of Form Factory Inc.

The Company signed a supply and licensing agreement with Made By Science Inc. (“MBS”), an Oregon, California multi state co-packaging and infused product manufacturer. MBS owns a variety of IP protected infusion, encapsulation, taste masking and manufacturing processes.

This Agreement provides that NORTHBUD will purchase from MBS raw, non-infused protein-based encapsulation powder (MX-17) to be used for infusion and formulation purposes in the Canadian market. NORTHBUD and MBS have established a per gram cost as well as a royalty agreement where NORTHBUD will pay a floating royalty on business to business sales and a consumer direct sale.

The companies intend to negotiate a master licensing agreement (“the Agreement”) to include the licensing and use of multiple proprietary food infusion technologies for which MBS will grant a master license for NORTHBUD to the use of the patented technology.

“Over the past 8 months our team has researched many technology solutions pertaining to encapsulation and infusion of cannabinoids into foods and beverages,” said Ryan Brown, Founder and CEO of North Bud Farms Inc. “This agreement secures us access to a premier technology partner allowing us to leverage a proven technology and tested processes from an advanced consumer market. We believe this will accelerate NORTHBUD’s goal of developing a food grade cannabinoid infused taste neutral ingredient as a first step towards creating products that will follow in compliance with the upcoming regulations regarding infused consumables. Over the coming months we look forward to working with both Food and Cannabis industry participants as we establish our development platform in preparation for the legalization of edibles and consumables which is anticipated in October 2019.”

“Made By Science has been relentlessly innovating the science driving the infused edibles industry to provide brands and consumers with safe, efficient and accurate products. As our team continues to position as a best in class manufacturer in the U.S., we have had our sights set on Canada as both critical to our long-term expansion and essential for our ability to export to international markets. NORTHBUD was an early believer in our technology and our team and we are excited to support their efforts with innovation and scale,” said Joshua Held, President of Form Factory Inc.

In accordance with the corporate stock option plan, North Bud Farms has issued 85,000 options at a strike price of $0.60 to advisors and consultants assisting with this project. These options will vest over a 24-month period.

About Made By Science Inc.
Made By Science Inc. is a wholly owned subsidiary of Form Factory Inc., a multi state manufacturer of cannabis infused food and beverage products.

For more information visit: www.madebyscience.co

About North Bud Farms Inc.
North Bud Farms Inc., through its wholly-owned subsidiary GrowPros MMP Inc. which was acquired in February 2018, is pursuing a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR).   North Bud Farms will be constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward- looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in North Bud Farms’ final long form prospectus dated August 21, 2018 which is available under the issuer’s SEDAR profile at www.sedar.com.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

INTERVIEW: North Bud Farms $NBUD.ca Discusses Licensing of #Cannabinoid Infusion Technology for Food and Beverage Platform

Posted by AGORACOM-JC at 4:02 PM on Thursday, September 27th, 2018

INTERVIEW: CFN Interviews Ryan Brown about $NBUD.ca Strategy $TLRY

Posted by AGORACOM-JC at 3:04 PM on Friday, September 21st, 2018

North Bud Farms Inc (C.NBUD) CEO Ryan Brown met with CannabisFN Media to lay out and explain the company’s strategic and future direction as the industry moves closer into Legalization 2.0.

The company is focusing on a sustainable production and procurement of cannabinoids while pursuing a license under the Access To Cannabis for Medical Purpose Regulations (ACMPR).